West Pharmaceutical Services, Inc. Revenue 2008–2025
West Pharmaceutical Services, Inc. reported $3.07B of revenue for fiscal 2025. That was 6.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +43.2%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $3.07B | +6.3% |
| FY 2024 | $2.89B | -1.9% |
| FY 2023 | $2.95B | +2.2% |
| FY 2022 | $2.89B | +2.0% |
| FY 2021 | $2.83B | +31.9% |
| FY 2020 | $2.15B | +16.7% |
| FY 2019 | $1.84B | +7.1% |
| FY 2018 | $1.72B | +7.4% |
| FY 2017 | $1.60B | +6.0% |
| FY 2016 | $1.51B | +7.8% |
| FY 2015 | $1.40B | -1.5% |
| FY 2014 | $1.42B | +3.9% |
| FY 2013 | $1.37B | +8.1% |
| FY 2012 | $1.27B | +6.2% |
| FY 2011 | $1.19B | +7.9% |
| FY 2010 | $1.10B | +4.6% |
| FY 2009 | $1.06B | +0.4% |
| FY 2008 | $1.05B | — |
Source: West Pharmaceutical Services, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open WST 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
West Pharmaceutical Services, Inc. reported $3.07B of revenue for fiscal 2025. That was 6.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +43.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for West Pharmaceutical Services, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeWest Pharmaceutical Services, Inc. — frequently asked questions
What is West Pharmaceutical Services, Inc.'s revenue?
West Pharmaceutical Services, Inc. (WST) reported revenue of $3.07B for fiscal year 2025, per its SEC filings.
How has West Pharmaceutical Services, Inc.'s revenue changed over time?
Between fiscal 2008 and 2025, WST's revenue grew at roughly 6.5% per year (compound annual rate), from $1.05B to $3.07B.
Where does this data come from?
Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.